Biometrics in the Payment Industry: "Almost Every Bank,

New Post Public Reply Private Reply Replies (0) Message Board
Roger Wilco leahanne #557
Biometrics in the Payment Industry: "Almost Every Bank, Retailer, Payment Company Is Looking at How to Incorporate Biometrics Into Their Future" -- Peter O'Neill -- FindBiometrics

POINT ROBERTS, WA and NEW YORK, NY--(Marketwired - November 06, 2015) - Investorideas.com, a global news source covering leading sectors including tech reports on the recent Money20/20 2015 Conference held at the Venetian in Las Vegas and the role biometrics will play in the future of the payment industry.

samssing_Pay_at_Money_2020-6b17f45834ae85e38fa538e68e143389.jpg

Money 20/20 is one of the largest events covering payments and financial services innovation and biometric technology was a key topic in many of the panel sessions, as well as being incorporated into many of the exhibiting technologies.

Bryan Yeager, an analyst at eMarketer Inc., in his presentation at Market Overview: Mobile Wallets & Payments referenced that, "The movie 'Back to the Future 2' featured biometrically authenticated payments in a scene where this guy asks Marty to thumb him $100 to save the clock tower. That shows they were looking at biometrics in payments back in 1985."

Video Clip: Bryan Yeager, Analyst, eMarketer Inc. at Money 20/20
https://www.youtube.com/watch?v=pQfiD_T4iGs

[youtube]https://www.youtube.com/watch?v=pQfiD_T4iGs[/youtube]

The industry has come a long way and is now very much a part of reality as noted in the session, 'Biometric Identity & its Applications in Financial Services & Payments', moderated and introduced by Peter O'Neill, President, FindBiometrics.

Peter told an attentive audience, "Biometric technology is more popular than ever before. New advances in biometrics have allowed for massive proliferation. All the big players are now involved; Apple, Microsoft, Samsung, Google, MasterCard, USAA, Toyota, Visa, Facebook, Ford, General Motors, TD, Scotia, Royal, CIBC, Alibaba, Qualcomm, PayPal, Intel, and on and on and on."



Commenting on the topic with Peter were some of the big names in the industry with speakers including Paul Burmester, CEO, Validsoft; Philippe Le Pape, VP Sales Director, Morpho (Safran); Bob Reany, Group Head & SVP, Identity Solutions, MasterCard; Rick Swenson, AVP Enterprise Fraud Prevention & Detection, USAA; and Conor White, President, Americas, Daon. They discussed how different biometric technologies including voice, face, fingerprint and iris recognition are enabling new applications in financial services and payments.

Video Clip: Biometric Identity & its Applications in Financial Services & Payments at Money 20/20 https://www.youtube.com/watch?v=_fcBGl_kWVw

Investorideas.com also talked to one of the exhibiting companies at Money 20/20 focusing on biometric security for the payment sector. Gino Pereira, CEO of NXT-ID shared how his company is taking a unique approach to payment technology. Unlike an Apple Pay, his company's Wocket® is separate from a phone. Since security concerns are a key inhibitor to mobile payment adoption, he feels he is on the right track.

They have also created dual authentication access with a combination of PIN and/or their voice recognition technology, VoiceMatch™.

Gino said, "All your information is stored in here - in this secure unit and as you select the items to pay, it programs one single card. In fact, it becomes a secure method by which you swipe and pay with the card of your choice. If you lose it, there is no identifying information on your card so nobody can take your credit card number. If you lose your Wocket®, all your information is stored securely so without the alpha numeric pin or voice biometrics to gain access, there is no way you can take over my Wocket. (www.wocketwallet.com)."

Video Clip: Gino Pereira, CEO of NXT-ID talks about Wocket:
https://www.youtube.com/watch?v=NHsKF663_t4

* Note there are some edits in this video due to background noises at Money 20/20 and part of the audio was re-recorded.

Peter O'Neill, President, FindBiometrics also noted in his introduction that since last year's panel, the biometrics and finance market has evolved significantly. "The world's most prominent mobile concerns have biometrically enabled M-payment platforms. Apple Pay, Samsung Pay, Android Pay, PayPal and Alipay - major payment networks, have integrated biometrics into their offerings and banks have embraced biometrics for phone, mobile and ATM banking."

Peter also said, "As data breaches continue to rise and as the password continues to prove totally ineffective and as the public yearns for a better, more convenient and secure way forward - almost every bank retailer and credit card company is looking at how to incorporate biometrics into their future."

About Money20/20 (http://www.money2020.com/)

As the industry's primetime conference and trade show, Money20/20 delivers the biggest scale, best audience and most engaging event. Money20/20 is the largest global event focused on payments and financial services innovation for connected commerce at the intersection of mobile, retail, marketing services, data and technology. With 10,000+ attendees, including more than 1,000+ CEOs, from 3,000+ companies and 75 countries, expected at our 2015 U.S. event, Money20/20 is critical to realizing the vision of disruptive ways in which consumers and businesses manage, spend and borrow money.

About Investorideas (http://www.investorideas.com/)

InvestorIdeas.com is a global investor news source that follows the money in mining, energy, renewable energy, water stocks, food and beverage (including organic and LOHAS, wine), defense and security, biotech, technology and mobile. We have also recently expanded our global coverage to include Latin American stocks, sports and entertainment.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Sign up for free news alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp

LogicMark Inc. (LGMK) Stock Research Links

LGMK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

You Call The Play Inc. (YCTP) Leads with Integrity in Betting

Updated Category News Views 154

Understanding You Call The Play Inc. (YCTP)'s Initiative In an important move for the sports betting landscape, You Call The Play Inc. (YCTP) has recently unveiled a national licensing plan and a groundbreaking measure called the Safe Bet Overlay™. This initiative is designed to foster trust and transparency within an industry that continues to grow rapidly across the...

Continue Reading
Cash for Houses Pro Earns Stellar Reputation with 5-Star Reviews

Updated Category News Views 167

Cash for Houses Pro Achieves 5-Star Reviews Cash for Houses Pro is celebrating their recent success in receiving numerous 5-star reviews on Google for their service known as 'Sell Your House Fast In Tampa FL For Cash'. This recognition reflects the team's dedication to providing homeowners with a seamless and stress-free home selling experience. About Cash for Houses Pro...

Continue Reading
Pfizer's Potential Transformation Following Starboard Investment

Updated Category News Views 77

Pfizer's Revised Price Target and Market Standing Recently, CFRA, a prominent financial research firm, elevated its price target for Pfizer Inc. (NYSE:PFE) from $30.00 to $31.00 per share. This adjustment comes while maintaining a 'Hold' rating on the stock, suggesting a careful observation of its market performance. The current price target reflects a valuation based on...

Continue Reading
Equinox Gold's Impressive Q2 Results Spark Stock Surge Today

Updated Category News Views 103

Equinox Gold Delivers Strong Quarterly Performance Equinox Gold Corp. EQX has seen its shares rise significantly following the release of its second-quarter financial results, which exceeded market expectations. Investors reacted favorably, driving the stock up on Thursday. Financial Highlights from the Quarter In the latest quarterly report, Equinox Gold announced...

Continue Reading
Investor Insights on Alexandria Real Estate Equities' Legal Challenges

Updated Category News Views 219

Understanding the Alexandria Real Estate Equities, Inc. Lawsuit Investors have an important opportunity arising from a lawsuit against Alexandria Real Estate Equities, Inc. (NYSE: ARE). A national shareholder rights litigation firm has initiated a class action alleging the Company has violated various securities laws. This situation has caught the attention of many...

Continue Reading